España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

ratiopharm españa, s.a. - dutasterida - excipientes: butilhidroxitolueno,glicerol,lecitina de soja - fÁrmacos usados en la hipertrofia prostÁtica benigna - inhibidores de la testosterona 5-alfa reductasa - dutasterida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

teva pharma s.l.u. - dutasterida - excipientes: butilhidroxitolueno,glicerol,lecitina de soja - fÁrmacos usados en la hipertrofia prostÁtica benigna - inhibidores de la testosterona 5-alfa reductasa - dutasterida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

krka, d.d., novo mesto - dutasterida - excipientes: propilenglicol monocaprilato,butilhidroxitolueno,glicerol - fÁrmacos usados en la hipertrofia prostÁtica benigna - inhibidores de la testosterona 5-alfa reductasa - dutasterida

Unión Europea - español - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - neoplasmas prostáticos - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - neoplasmas prostáticos - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Unión Europea - español - EMA (European Medicines Agency)

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - inmunológicos para suidos - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. otro factor clave para la contaminación del verraco, el escatol, también se puede reducir como un efecto indirecto. los comportamientos agresivos y sexuales (de montaje) también se reducen. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

Unión Europea - español - EMA (European Medicines Agency)

virbac s.a. - acetato de osaterona - urológicos - perros - tratamiento de la hipertrofia prostática benigna (hpb) en perros machos.

Cuba - español - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

laboratorios vijosa s.a. de c.v. - cipionato de testosterona - solución inyectable im. - 100 mg/ml

Chile - español - ISPC (Instituto de Salud Pública de Chile)

laboratorio biopas s.a. - testosterona - sin formulas

Chile - español - ISPC (Instituto de Salud Pública de Chile)

eurofarma chile spa - testosterona - sin formulas